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In this issue of JACC: Cardiovascular Interventions, Tu et al.
(1) report on an initial validation study for a less-invasive
approach to derive fractional ﬂow reserve (FFR) based on the
coronary angiogram. The investigators should be congratu-
lated on developing an innovative means to expand the
diagnostic value of angiography by including physiological
ischemic assessment, potentially broadening access FFR
data to every patient undergoing cardiac catheterization.See page 768Clinical Relevance of FFR Derived From
Quantitative Coronary Angiography
Revascularization of coronary artery disease should be based
on objective evidence of ischemia. The clinical utility of
invasive FFR-guided percutaneous coronary intervention
(PCI) to selectively treat patients with stable ischemic heart
disease using an FFR threshold of 0.8 to deﬁne ischemia is
well established (2,3). FFR-guided therapy was shown to
reduce major adverse cardiac events (death, myocardial
infarction, repeat revascularization) by approximately 28%
compared with angiography-guided PCI (2), and by 68%
compared with optimal medical therapy alone (3). Ischemia-
guided PCI based on FFR is not only cost effective but
also net cost saving compared with PCI based on anatomy
alone (4).*Editorials published in JACC: Cardiovascular Interventions reﬂect the views of
the authors and do not necessarily represent the views of JACC: Cardiovascular
Interventions or the American College of Cardiology.
From the Section of Cardiology, Yale University School of Medicine, New Haven,
Connecticut. Both authors have reported that they have no relationships relevant to the
contents of this paper to disclose.The ability of FFR to identify patients who will beneﬁt
most from revascularization represents a major advance in
the ﬁeld of interventional cardiology, and has contributed to
the very low short-term and long-term event rates now
achievable with PCI. Accordingly, FFR has become an
integral part of the ischemic evaluation, ﬁnding its way into
PCI guidelines as Class IA recommendation from the
European Society of Cardiology and Class IIa (Level of
Evidence: A) in the U.S. joint guidelines (5,6).
In addition, FFR has become an important diagnostic
safety net for interventionalists in the evaluation of inter-
mediate coronary lesions, particularly in the current climate
of intense scrutiny of perceived overuse of PCI. Increasing
governmental oversight of PCI utilization is planned in the
United States, including by the Center for Medicare &
Medicaid Services as a condition of payment (7). The
methodology for such ascertainment has not been speciﬁed;
however, the burden of proof that an intervention was
appropriate will ultimately lie with the operator, and the
clear linkage between FFR and clinically signiﬁcant disease
provides the evidence necessary, as outlined in the guidance
on appropriate use criteria for coronary revascularization (8).
In this context, FFR derived from quantitative coronary
angiography (FFRQCA) described by Tu et al. (1) is a
timely addition to our diagnostic armamentarium, and is
clearly relevant to daily clinical practice. With a fully inte-
grated and automated software solution, the processing time
is expected to be <2 min for complete longitudinal FFR
computation of each coronary vessel and its major side
branches; in other words, FFR of the entire coronary tree
would be obtained in <10 min at the time of angiography.
Based on the reported validation against invasive FFR, the
high diagnostic accuracy of FFRQCA (88%) relative to the
traditional anatomic angiographic measures of minimal
lumen area (64%) and percent diameter stenosis (68%) offers
better discrimination of the clinical signiﬁcance of inter-
mediate lesions. In contrast with invasive FFR, which
selectively interrogates a single lesion at a time, FFRQCA
permits longitudinal assessment of the entire coronary vessel,
and if necessary the entire coronary tree, and can assist in
identifying additional ischemia-producing lesions that
would otherwise be missed. FFRQCA also eliminates the
risks associated with intracoronary pressure wire placement
through a guiding catheter and systemic heparin adminis-
tration. Ultimately, these advantages could enable more
appropriate, more complete ischemic revascularization for
our patients.Methodology of FFRQCA
The unique feature of FFRQCA that likely explains the high
reported accuracy is its derivation from computational ﬂuid
dynamics applied to reconstruction of the individual’s
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779coronary tree (coronary vessel including side branches). This
is accomplished using validated 3-dimensional (3D) quan-
titative coronary angiography (QCA) and hyperemic volu-
metric ﬂow rates derived from Thrombolysis In Myocardial
Infarction frame count, adjusted to parent and daughter
vessel ﬂow distribution in side branches. The inclusion of
major side branches allows better adjustment for differences
in myocardial mass subtended by the interrogated vessel, and
the use of individual hyperemic ﬂow better accounts for
distal microvascular disease, providing a better approxima-
tion of invasive measures overall. This is also the primary
difference between FFRQCA and FFR derived from com-
puted tomography, which uses empiric ﬂow derivation
based on average population–based physiological model
assumptions under rest conditions, rather than individual
hyperemiadlikely contributing to the lower observed accu-
racy of FFR derived from computed tomography compared
with the pressure wire technique (9).Acquisition Implications and Requirements
The current FFRQCA application is simple and can be
applied to standard diagnostic angiography technique
with minimal impact on acquisition. 3D QCA requires 2
angiographic projections of each coronary artery with
minimal overlap and foreshortening, obtained at least 25
apart; larger angles do not improve 3D accuracy (10). In
addition to using intracoronary nitroglycerin, at least 1
projection should be obtained during either intracoronary or
intravenous adenosine-induced hyperemia. A mean arterial
pressure from the guiding catheter and a hematocrit are the
only additional inputs necessary to obtain FFRQCA. These
requirements are minimal compared with invasive FFR, and
should be straightforward to incorporate into routine clinical
practice. Therefore, FFRQCA has the potential to reduce the
barrier to physiological assessment in the catheterization
laboratory, and expand its clinical utility by reducing
unnecessary revascularization of insigniﬁcant lesions and
enabling identiﬁcation of additional clinically signiﬁcant
lesions.Validity of FFRQCA
The diagnostic accuracy of FFRQCA reported by Tu et al. (1)
is very good (88%), with an area under the receiver-operating
characteristic curve of 0.93, a negative predictive value of
91%, and a positive predictive value of 82% compared with
invasive FFR. The study population was derived from 4
separate centers and appropriately reﬂects the target patient
population with intermediate lesions (diameter stenosis
46.6  7.3%) most relevant for FFR interrogation. The
narrow standard deviation points to the homogeneity ofintermediate lesions included in the study, minimizing
outliers (extremes of stenosis) that would otherwise bias the
validation results. In addition, this ﬁrst validation study
demonstrated reproducible and accurate results of FFRQCA
in a range of relevant clinical scenarios including: 1) a
spectrum of challenging lesions (including 64% bifurca-
tions); 2) acquisition at different frame counts (15 and
30 frames/s); 3) use of different angiographic systems
(Siemens, Philips, GE); and 4) different routes of adenosine
administration (intravenous and intracoronary). Although
this validation represents an exciting ﬁrst step toward a new
technology, additional evidence will be required to conﬁrm
these results and the feasibility of implementation in real-
world clinical practice. Validation in more complex lesion
subsets (e.g., eccentric, angulated, tortuous, or calciﬁed
lesions), along with conﬁrmation that the reported accuracy
is generalizable to calculations based on angiograms obtained
outside the clinical trial environment, will be critical. The
clinical relevance of this method in deﬁning signiﬁcant
nonculprit lesions in patients with acute coronary syndromes
will also require veriﬁcation.Conclusions
As a new technology, FFRQCA should be received as a
welcome addition to our diagnostic tool kit in the cathe-
terization laboratory. We eagerly await conﬁrmation of these
results in a fully integrated, low-latency system that will be
necessary to enable widespread application of FFR-guided
PCI, improving the risk stratiﬁcation and, ultimately, the
outcomes of patients with ischemic heart disease.
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